Atlas Trials

Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease

Clinical trial NCT01144962 · COMPLETED

Trial details

NCT number
NCT01144962
Sponsor
Leiden University Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Crohn's DiseaseFistula
Start date
2010-06-01
Primary completion
2014-09-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.